Ark Diagnostics, Inc.
Fremont, CA
- UEI
- YFBTQKJJ3MW7
- CAGE
- 46Y91
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 48089 Fremont Blvd, Fremont, CA 94538, USA
- Website
- ark-tdm.com
- Founded
- 2003
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $74,504 |
| FY2024 | $35,890 |
| FY2023 | $142,036 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Ark Diagnostics, Inc., doing business as Ark Diagnostics Inc., is a privately held company that develops and commercializes in vitro diagnostic immunoassays for managing drug levels. From conception to commercialization, ARK utilizes its scientific expertise and industry knowledge to deliver reagents, assay kits, and other consumable laboratory supplies.
Ark Diagnostics has been awarded numerous prime federal contracts and delivery orders to provide diagnostic testing products to various agencies within the Department of Defense. These awards have included firm fixed price purchase orders and blanket purchase agreement (BPA) calls from the Department of the Army Medical Command, Defense Health Agency, and Department of the Air Force for reagents, assay kits, and consumable supplies used in laboratory testing. Ark has provided methotrexate assay kits, fentanyl assay kits, anesthesia and blood transfusion supplies, and other reagent peripherals. The company has not received any set-aside awards to date.
Ark Diagnostics, Inc. holds an $8 million single award blanket purchase agreement from the Defense Health Agency to provide reagents and consumable supplies through February 2025. Under this BPA, Ark has received two call orders valued at $45,000 each - one to deliver methotrexate reagents and kits to DHA's headquarters by September 2022, and another to provide reagent peripherals and consumables for the Department of Pathology at a Fremont, California location by September 2021. The BPA enables DHA to place fixed price calls on an as-needed basis for Ark's laboratory testing products to support its worldwide health services mission.
Quick answers
Is Ark Diagnostics, Inc. registered in SAM.gov?
Yes. Ark Diagnostics, Inc.'s SAM.gov registration is active through February 5, 2027.
What is Ark Diagnostics, Inc.'s CAGE code?
Ark Diagnostics, Inc.'s CAGE code is 46Y91, and its Unique Entity ID (UEI) is YFBTQKJJ3MW7.
How much has Ark Diagnostics, Inc. received in federal contracts?
Federal contracts obligated $74,504 to Ark Diagnostics, Inc. in fiscal year 2025 and $252,430 in fiscal years 2023 through 2027.
What is Ark Diagnostics, Inc.'s most recent federal award?
Ark Diagnostics, Inc.'s most recent federal contract award is Reagents - methotrexate assay kit - C pack green - base year and all four option years (W81K0023P0275), from Medical Command (Army), on October 1, 2023.
On GovTribe
See Ark Diagnostics, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors